(S1 (S (S (NP (NP (NNS PBMCs)) (PP (IN from) (NP (NN CF) (NNS patients)))) (VP (VBP do) (RB not) (VP (VB produce) (NP (NP (VBN increased) (NNS amounts)) (PP (IN of) (NP (NN IL-1beta))))))) (. .)))
(S1 (S (S (NP (NP (NNS PBMCs)) (PP (IN from) (NP (NP (NP (NN CF) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 17-20)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 15-19)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN primed) (PP (IN with) (NP (NP (NP (NN LPS)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (UCP (ADJP (JJ overnight)) (CC and) (VP (VBN stimulated) (PP (IN with) (NP (NP (NP (ADJP (FW P.) (FW aeruginosa)) (NN PAO1)) (PRN (-LRB- -LRB-) (NP (NN MOI) (JJ =) (CD 1)) (-RRB- -RRB-))) (, ,) (NP (NP (ADJP (FW P.) (FW aeruginosa)) (NN PAO1)) (VP (VBG lacking) (NP (NP (NP (NN exsA)) (PRN (-LRB- -LRB-) (NP (NN MOI) (JJ =) (CD 1)) (-RRB- -RRB-))) (, ,) (NP (NP (NN ATP)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mM)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NN Poly-LRB-dA:dT-RRB-)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN microg/ml)) (-RRB- -RRB-)))))))) (PP (IN for) (NP (CD 24) (NNS hours)))))))))) (. .)))
(S1 (S (S (NP (NP (FW P.) (FW aeruginosa)) (VP (VBG lacking) (NP (NN exsA)))) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (NP (NN type) (CD III) (NN secretion)) (NN control)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (JJ wild-type) (FW P.) (FW aeruginosa)))))))))) (. .)))
(S1 (S (S (NP (NNS Supernatants)) (VP (VBD were) (VP (VBN assayed) (PP (IN for) (NP (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NN IL-1beta)) (CC and) (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NN IL-8))))))) (. .)))
